B2M and neoplasm: The combination of impaired HLA class I antigen expression resulting from β2M mutation and the reduction of an immunosuppressive T cell population may heavily promote the proliferation of tumor cells that are less immunogenic and more inclined to evade surveillance in the process of immunoediting [75].